Related Experiment Video
Updated: Aug 14, 2025

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging
Published on: June 21, 2024
Lung function before and after COVID-19 in young adults: A population-based study.
Ida Mogensen1, Jenny Hallberg1,2, Sophia Björkander1
1Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Mild-to-moderate coronavirus disease 2019 (COVID-19) did not impact long-term lung function in young adults. Asthma, allergic sensitization, or inhaled corticosteroid (ICS) use did not alter these findings in the study population.
Area of Science:
- Pulmonology
- Infectious Diseases
- Epidemiology
Background:
- Limited evidence exists on the long-term effects of mild-to-moderate COVID-19 on young adults' lung function.
- Investigating potential long-term respiratory sequelae in this demographic is crucial.
Purpose of the Study:
- To assess the impact of COVID-19 on lung function in young adults.
- To determine if asthma, allergic sensitization, or inhaled corticosteroid (ICS) use modifies this impact.
Main Methods:
- Utilized data from the population-based BAMSE cohort, comparing lung function (spirometry) before and after the COVID-19 pandemic.
- Defined COVID-19 seropositivity using SARS-CoV-2 specific IgG, IgM, and/or IgA levels.
- Analyzed changes in FEV1, FVC, and FEV1/FVC ratio, examining the influence of allergic sensitization and ICS use in seropositive individuals.
Main Results:
- No significant differences in lung function changes (FEV1, FVC, FEV1/FVC) were observed between COVID-19 seropositive and seronegative young adults.
- These findings held true even for participants with asthma.
- Allergic sensitization and ICS use did not influence lung function outcomes among seropositive participants.
Conclusions:
- Mild-to-moderate COVID-19 does not appear to have a long-term negative impact on lung function in young adults.
- Pre-existing conditions like asthma and allergic sensitization, or the use of ICS, did not modify the lung function outcomes post-COVID-19.
Related Concept Videos
Lung Capacity
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Respiratory Volumes and Capacities

